EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Therapeutic study of the nausea and vomiting caused by chemotherapy medications by olanzapine to triple antiemetic therapy in Iraqi cancer patients

Ghufran salah ahmed, Khadim ali khadim2, Nabeel mudheher talib

Al Mustansiriyah Journal of Pharmaceutical Sciences · 2023

DOI: 10.32947/ajps.v23i2.1013 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Al Mustansiriyah Journal of Pharmaceutical Sciences, 2023. Verfasst von Ghufran salah ahmed und 2 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background:Chemotherapy-caused nausea and vomiting is a health problem in cancer patients. Olanzapine is used with serotonin receptor antagonists plus dexamethasone post Neurokinin 1 receptor antagonists as the antiemetic.

Objective

The study aimed to determine the efficacy of (5 and 10) mg of olanzapine with antiemetic drugs against chemotherapy-induced nausea and vomiting.

Methods

The study groups are Group S: received triple antiemetic therapy aprepitant at (1-3) day, dexamethasone at (1-4) day, and ondansetron only on the first day. Group O5: received olanzapine 5 mg with triple antiemetic therapy aprepitant (1-3) days, dexamethasone (1-4) day, ondansetron the first day, and olanzapine 5 mg (1-4) days. Group O10: received (olanzapine 10 mg with triple antiemetic therapy) aprepitant (1-3) days, dexamethasone (1-4) days, ondansetron day 1, and olanzapine 10 mg (1-4) days. The cancer was diagnosed by mamograph; the MAT score was used to control chemotherapy-caused nausea and vomiting.

Results

Higher acute and delayed nausea was observed in group S than in groups O5 and O10. Overall, nausea control was increased in group S than in groups O5 and O10. There was no significant difference between the different study groups.

Conclusion

Olanzapine 5 mg and 10 mg could treat nausea more than triple antiemetic in patients with nausea.

Zitieren

APA

ahmed, G. S., khadim2, K. A., & talib, N. M. (2023). Therapeutic study of the nausea and vomiting caused by chemotherapy medications by olanzapine to triple antiemetic therapy in Iraqi cancer patients. Al Mustansiriyah Journal of Pharmaceutical Sciences. https://doi.org/10.32947/ajps.v23i2.1013

Vancouver

ahmed GS, khadim2 KA, talib NM. Therapeutic study of the nausea and vomiting caused by chemotherapy medications by olanzapine to triple antiemetic therapy in Iraqi cancer patients. Al Mustansiriyah Journal of Pharmaceutical Sciences. 2023. doi:10.32947/ajps.v23i2.1013

BibTeX
@article{ahmed2023,
  author = {ahmed, Ghufran salah and khadim2, Khadim ali and talib, Nabeel mudheher},
  title = {Therapeutic study of the nausea and vomiting caused by chemotherapy medications by olanzapine to triple antiemetic therapy in Iraqi cancer patients},
  journal = {Al Mustansiriyah Journal of Pharmaceutical Sciences},
  year = {2023},
  doi = {10.32947/ajps.v23i2.1013}
}
Kostenlos starten →